I'll be interested to see whether the initial cohort treated with PXS 5505 alone respond in a clinically significant fashion over time. Of course, a favourable synergistic clinical response with PXS 5505 combined with a JAK inhibitor would also provide a most desirable outcome.
I'll be interested to see whether the initial cohort treated...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.10M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.6¢ | 1.5¢ | $6.213K | 390.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 5012750 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 932112 | 6 |
View Market Depth
| Last trade - 15.55pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 1.5¢ | 1.6¢ | 1.5¢ | 41480 | ||
| Last updated 12.25pm 07/05/2024 ? | |||||
| SNT (ASX) Chart |